Search results

In May 2023, The Honourable Dr Annabelle Bennett, ANSTO Board Chair, shared ANSTO's Statement of Intent with the Minister for Industry, Science and Technology.

The installation of a cold neutron source (CNS), a component that reduces the energy and speed of the neutrons from a research reactor for use in scientific instruments, was successfully completed in September 2024.

A unique scientific capability comprising a single research platform for high-fidelity simulation, real-time dosimetry, and biological response data is available all from a neutron instrument.

ANSTO User Meeting 2021 - Speakers

Congress marks watershed moment for nuclear medicine and ANSTO

Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia

Thirty years of ANSTO's unique capability in monitoring fine particle pollution provides insight on bushfire smoke.

Australian researchers and clinicians have recently returned from Japan where they investigated the use of advanced radiation therapy for cancer using heavy ions at particle therapy facilities on a study tour .

Publications and resources from the Powder Diffraction beamline.